BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24488564)

  • 1. Molecular and cytogenetic characterization of expanded B-cell clones from multiclonal versus monoclonal B-cell chronic lymphoproliferative disorders.
    Henriques A; Rodríguez-Caballero A; Criado I; Langerak AW; Nieto WG; Lécrevisse Q; González M; Cortesão E; Paiva A; Almeida J; Orfao A
    Haematologica; 2014 May; 99(5):897-907. PubMed ID: 24488564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined patterns of IGHV repertoire and cytogenetic/molecular alterations in monoclonal B lymphocytosis versus chronic lymphocytic leukemia.
    Henriques A; Rodríguez-Caballero A; Nieto WG; Langerak AW; Criado I; Lécrevisse Q; González M; Pais ML; Paiva A; Almeida J; Orfao A
    PLoS One; 2013; 8(7):e67751. PubMed ID: 23844084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjects with chronic lymphocytic leukaemia-like B-cell clones with stereotyped B-cell receptors frequently show MDS-associated phenotypes on myeloid cells.
    Rodríguez-Caballero A; Henriques A; Criado I; Langerak AW; Matarraz S; López A; Balanzategui A; González M; Nieto WG; Cortesão E; Paiva A; Almeida J; Orfao A
    Br J Haematol; 2015 Jan; 168(2):258-67. PubMed ID: 25252186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
    Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia.
    Maura F; Cutrona G; Fabris S; Colombo M; Tuana G; Agnelli L; Matis S; Lionetti M; Gentile M; Recchia AG; Di Raimondo F; Musolino C; Ilariucci F; Di Renzo N; Pesce E; Molica S; Federico M; Cortelezzi A; Morabito F; Ferrarini M; Neri A
    PLoS One; 2011; 6(8):e24313. PubMed ID: 21897877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What does it mean I have a monoclonal B-cell lymphocytosis?: Recent insights and new challenges.
    Scarfò L; Ghia P
    Semin Oncol; 2016 Apr; 43(2):201-8. PubMed ID: 27040697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In non-follicular lymphoproliferative disorders, IGH/BCL2-fusion is not restricted to chronic lymphocytic leukaemia.
    Baseggio L; Geay MO; Gazzo S; Berger F; Traverse-Glehen A; Ffrench M; Hayette S; Callet-Bauchu E; Verney A; Morel D; Jallades L; Magaud JP; Salles G; Felman P
    Br J Haematol; 2012 Aug; 158(4):489-98. PubMed ID: 22686190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.
    Morabito F; Mosca L; Cutrona G; Agnelli L; Tuana G; Ferracin M; Zagatti B; Lionetti M; Fabris S; Maura F; Matis S; Gentile M; Vigna E; Colombo M; Massucco C; Recchia AG; Bossio S; De Stefano L; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Tassone P; Negrini M; Monti S; Rossi D; Gaidano G; Ferrarini M; Neri A
    Clin Cancer Res; 2013 Nov; 19(21):5890-900. PubMed ID: 24036852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic aberrations and immunoglobulin VH gene mutations in clinically benign CD5- monoclonal B-cell lymphocytosis.
    Amato D; Oscier DG; Davis Z; Mould S; Zheng J; Kolomietz E; Wang C
    Am J Clin Pathol; 2007 Aug; 128(2):333-8. PubMed ID: 17638670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The
    Perez-Chacon G; Zapata JM
    Front Immunol; 2021; 12():627602. PubMed ID: 33912159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome.
    Criado I; Rodríguez-Caballero A; Gutiérrez ML; Pedreira CE; Alcoceba M; Nieto W; Teodosio C; Bárcena P; Romero A; Fernández-Navarro P; González M; Almeida J; Orfao A;
    Haematologica; 2018 Jul; 103(7):1198-1208. PubMed ID: 29567775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia.
    Colombo M; Cutrona G; Reverberi D; Fabris S; Neri A; Fabbi M; Quintana G; Quarta G; Ghiotto F; Fais F; Ferrarini M
    Mol Med; 2011; 17(7-8):834-9. PubMed ID: 21541442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell receptor usage correlates with the sensitivity to CD40 stimulation and the occurrence of CD4+ T-cell clonality in chronic lymphocytic leukemia.
    Zaborsky N; Holler C; Geisberger R; Asslaber D; Gassner FJ; Egger V; Piñón-Hofbauer J; Kocher T; Hartmann TN; Greil R; Egle A
    Haematologica; 2015 Aug; 100(8):e307-10. PubMed ID: 25911550
    [No Abstract]   [Full Text] [Related]  

  • 14. Frequency of monoclonal B-cell lymphocytosis in relatives of patients with chronic lymphocytic leukemia.
    Villegas Gracia R; Franco Alzate C; Rendón Henao J; Torres Hernández JD; Jaramillo Arbelaez PE
    Colomb Med (Cali); 2016 Jun; 47(2):81-6. PubMed ID: 27546929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell lymphocytosis in relatives of Colombian patients with chronic B-cell lymphoproliferative disorders.
    Celis M; Navarro Y; Serrano N; Martínez D; Nieto W
    Biomedica; 2023 Dec; 43(Sp. 3):66-78. PubMed ID: 38207149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BIRC-3 mutated monoclonal B lymphocytosis without evolution to chronic lymphocytic leukemia (CLL).
    Nasr AA; Fund X; Barreau S; Desterke C; Borie C; Oudrhiri N; Faivre J; Bennaceur-Griscelli A; Turhan AG
    Leuk Lymphoma; 2024 May; 65(5):692-695. PubMed ID: 38293748
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
    Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
    Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of DNA damage and alteration of the DNA damage response in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
    Popp HD; Flach J; Brendel S; Ruppenthal S; Kleiner H; Seifarth W; Schneider S; Schulze TJ; Weiss C; Wenz F; Hofmann WK; Fabarius A
    Leuk Lymphoma; 2019 Mar; 60(3):795-804. PubMed ID: 30376743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of immunoglobulin heavy and light chain gene expression in chronic lymphocytic leukemia and related disorders.
    Nakahashi H; Tsukamoto N; Hashimoto Y; Koiso H; Yokohama A; Saitoh T; Uchiumi H; Handa H; Murakami H; Nojima Y; Karasawa M
    Cancer Sci; 2009 Apr; 100(4):671-7. PubMed ID: 19220298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression.
    Ojha J; Secreto C; Rabe K; Ayres-Silva J; Tschumper R; Dyke DV; Slager S; Fonseca R; Shanafelt T; Kay N; Braggio E
    Leukemia; 2014 Dec; 28(12):2395-8. PubMed ID: 25034147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.